MedPath

ARMADILLO Trial: a research trial evaluating the effect of delivering sexual and reproductive health (SRH) information via SMS to young people on SRH learning and beliefs

Not Applicable
Completed
Conditions
Sexual and reproductive health
Not Applicable
Registration Number
ISRCTN85156148
Lead Sponsor
DP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)
Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29996854 protocol 2019 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/31573939 Implementation lessons (added 03/10/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34992099/ results in Kenya (added 10/01/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35143513/ results in Peru (added 11/02/2022) 2020 Results article in http://dx.doi.org/10.1136/bmjopen-2019-034769 Mixed-methods study on pharmacies as contraception providers to Kenyan young people: who uses them and why? (added 15/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1452
Inclusion Criteria

Eligibility criteria for the general ARMADILLO study is as follows:
1.Youth between the ages of 13-24 (age range narrowed as needed for each site);
2.Literate
3.Have their own mobile phone (meaning it is primarily in their possession, and they control when and with whom they share access) and report regular use
4.Have a mobile phone with them at the time of recruitment
5.Report current use of text messaging

Exclusion Criteria

Those that do not meet the eligibility criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath